PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization

Peritoneal Dialysis International

Volumn 24, Issue 4, 2004, Pages 392-398

  Erixon, Martin ^a,b   Lindén, Torbjörn ^a   Kjellstrand, Per ^a   Carlsson, Ola ^a   Ernebrant, Malin ^a   Forsbäck, Gunita ^a   Wieslander, Anders ^a   Jöhnson, Jan Åke ^b  

^a Gambro AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

3,4 DGE; Cytotoxicity; Glucose; Sterilization; Storage

Indexed keywords

3 DEOXYGLUCOSONE; 3,4 DIDEOXYGLUCOSONE 3 ENE; 5 HYDROXYMETHYLFURFURAL; ACETALDEHYDE; FORMALDEHYDE; GLUCOSE DEGRADATION PRODUCT; GLUCOSE DERIVATIVE; GLYOXAL; METHYLGLYOXAL; PERITONEAL DIALYSIS FLUID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DISINFECTION; GROWTH INHIBITION; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; STORAGE; STORAGE TEMPERATURE; TEMPERATURE DEPENDENCE;

EID: 4444286745     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400416     Document Type: Article

References (24)

1. Nilsson-Thorell CB, Muscalu N, Andrén AHG, Kjellstrand PTT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13:208-13.
2. Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A. 3,4-Dideoxyglucosone-3-ene (3,4-DGE), a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002; 62:697-703.
3. Lindén T, Forsbäck G, Deppisch R, Henle T, Wieslander A. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int 1998; 18:290-3.
4. Cendoroglo M, Sundaram S, Jaber BL, Pereira BJ. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Am J Kidney Dis 1998; 31:273-82.
5. Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40:77-9.
6. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000; 11:729-39.
7. Morgan LW, Wieslander A, Davies M, Horiuchi T, Ohta Y, Beavis JM, et al. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int 2003; 64:1854-66.
8. Jonasson P, Bagge U, Wieslander A, Braide M. Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity in rat peritoneal venules. Perit Dial Int 1996; 16(Suppl 1):S137-40.
9. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 2001; 13:480-9.
10. Musi B, Braide M, Carlsson O, Wieslander A, Albrektsson A, Ketteler M, et al. Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats. Perit Dial Int 2004; 24:37-47.
11. Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, Stelin G, et al. Long-term clinical effects of peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59:348-57.
12. Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, et al. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003; 63: 298-305.
13. Tuncer M, Sarikaya M, Sezer T, Özcan S, Süleymanlar G, Yakupoglu G, et al. Chemical peritonitis associated with high dialysate acetaldehyde concentrations. Nephrol Dial Transplant 2000; 15:2037-40.
14. Schalkwijk CG, Posthuma N, ten Brink HJ, ter Wee PM, Teerlink T. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999; 19: 325-33.
15. Ulbricht RJ, Northup SJ, Thomas JA. A review of 5-hydroxymethylfurfural (HMF) in parenteral solutions. Fundam Appl Toxicol 1984; 4:843-53.
16. Kjellstrand P, Martinson E, Wieslander A, Holmquist B. Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: influence of time and temperature. Perit Dial Int 1995; 15:26-32.
17. Wieslander AP, Andrén A, Martinson E, Kjellstrand P, Hultqvist M. Toxicity of effluent peritoneal dialysis fluid. Adv Perit Dial 1993; 9:31-5.
18. 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int 1996; 49:861-7.
19. Anet EFLJ. 3-Deoxyglycosuloses (3-deoxyglycosones) and the degradation of carbohydrates. Adv Carbohydr Chem 1964; 19:181-218.
20. Wieslander A, Lindén T, Musi B, Carlsson O, Deppisch R. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids. Perit Dial Int 2000; 20(Suppl 5):S23-7.
21. Linden T, Musi B, Järkelid L, Forsbäck G, Kjellstrand P, Deppisch R, et al. Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells. Perit Dial Int 2001; 21:607-24.
22. Wieslander AP, Deppisch R, Svensson E, Forsbäck G, Speidel R, Rippe B. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995; 15:158-64.
23. Kjellstrand P, Erixon M, Wieslander A, Linden T, Martinson E. Temperature: the single most important factor for degradation of glucose during storage. Perit Dial Int 2004; 24:385-91.
24. Zimmeck T, Tauer A, Fuenfrocken M, Pischetsrieder M. How to reduce 3-deoxyglucosone and acetaldehyde in peritoneal dialysis fluids. Perit Dial Int 2002; 22: 350-6.